327 related articles for article (PubMed ID: 12592981)
1. The Canadians are killing us.
Struble RA
Pharos Alpha Omega Alpha Honor Med Soc; 2002; 65(4):58-9. PubMed ID: 12592981
[No Abstract] [Full Text] [Related]
2. American pharmaceutical prices.
Alagona P
Pharos Alpha Omega Alpha Honor Med Soc; 2002; 65(4):58. PubMed ID: 12592980
[No Abstract] [Full Text] [Related]
3. Exploring the rise in American pharmaceutical prices.
Marwaha A
Pharos Alpha Omega Alpha Honor Med Soc; 2002; 65(2):11-5. PubMed ID: 12099112
[No Abstract] [Full Text] [Related]
4. Will lower drug prices jeopardize drug research? A policy fact sheet.
Light DW; Lexchin J
Am J Bioeth; 2004; 4(1):W1-4. PubMed ID: 15035915
[No Abstract] [Full Text] [Related]
5. Opinion: price controls on prescription drugs.
Franks B
N J Med; 2004 Apr; 101(4):56, 55. PubMed ID: 15103791
[No Abstract] [Full Text] [Related]
6. Rx: higher prices.
Kosterlitz J
Natl J (Wash); 1993 Feb; 25(7):396-9. PubMed ID: 10125572
[TBL] [Abstract][Full Text] [Related]
7. PhRMA sues on 340B orphans.
Lee J
Mod Healthc; 2013 Oct; 43(40):17. PubMed ID: 24340726
[No Abstract] [Full Text] [Related]
8. Prescription-drug prices.
Frank RG
N Engl J Med; 2004 Sep; 351(14):1375-7. PubMed ID: 15459294
[No Abstract] [Full Text] [Related]
9. The pharmaceutical industry versus Medicaid--limits on state initiatives to control prescription-drug costs.
Mello MM; Studdert DM; Brennan TA
N Engl J Med; 2004 Feb; 350(6):608-13. PubMed ID: 14762190
[No Abstract] [Full Text] [Related]
10. Pricing pain: relief in sight on drug costs?
J Am Health Policy; 1992; 2(6):28-31. PubMed ID: 10122415
[TBL] [Abstract][Full Text] [Related]
11. Rx: Canadian drugs.
Bugden S
N Engl J Med; 2004 Mar; 350(11):1155. PubMed ID: 15014193
[No Abstract] [Full Text] [Related]
12. Can price and regulatory controls replace free market competition in the drug industry?
Buc NL; Levitt GM
Healthspan; 1993 Nov; 10(10):30-2. PubMed ID: 10130839
[No Abstract] [Full Text] [Related]
13. The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs.
Gudiksen KL; King JS
J Leg Med; 2019; 39(2):95-120. PubMed ID: 31503534
[No Abstract] [Full Text] [Related]
14. New rules for US drug reimbursement.
Bouchie A
Nat Biotechnol; 2003 Oct; 21(10):1119-20. PubMed ID: 14520382
[No Abstract] [Full Text] [Related]
15. Meeting resistance. Express Scripts-Medco deal called anti-competitive.
Lee J
Mod Healthc; 2011 Aug; 41(32):10-1. PubMed ID: 21879692
[No Abstract] [Full Text] [Related]
16. Pharmaceutical costs. An overview and analysis of legal and policy responses by the states.
Latham SR
J Leg Med; 2003 Jun; 24(2):141-73. PubMed ID: 12775406
[No Abstract] [Full Text] [Related]
17. Pharmac dogma.
Douglas B
N Z Med J; 2007 Feb; 120(1249):U2430. PubMed ID: 17308566
[No Abstract] [Full Text] [Related]
18. CMS retreats on Part D rule intended to reduce drug costs and improve access.
Dickson V
Mod Healthc; 2014 Mar; 44(11):10. PubMed ID: 24830094
[No Abstract] [Full Text] [Related]
19. Prescription drug prices in Canada.
Gross D
Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 Jun; (IB62):1-22. PubMed ID: 12807123
[No Abstract] [Full Text] [Related]
20. Gift giving.
Raszkowski RR
S D J Med; 2002 Dec; 55(12):513-4. PubMed ID: 12516357
[No Abstract] [Full Text] [Related]
[Next] [New Search]
